Senior insider sale
Chief Executive Officer at STARLING ONCOLOGY, INC. — senior position signals high conviction
$1.95M
298.85K shares
What this filing means
HIVELY BRAD plans to sell 298.85K shares of STARLING ONCOLOGY, INC. valued at approximately $1.95M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/21/2026ACC: 0001950047-26-008532
DirectorOfficer· Chief Executive Officer
Since Nov 2021
298.85K
Shares to sell
$1.95M
Approx. market value
298.85K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months3
Restricted Stock Units
N/A
11/21/2025
19.07KOpen Market Purchase
Cash
12/2/2024
50KOpen Market Purchase
Cash
11/26/2024
229.78KTotal acquired298.85K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/21/2025 | Restricted Stock Units N/A | 19.07K | — |
12/2/2024 | Open Market Purchase Cash | 50K | — |
11/26/2024 | Open Market Purchase Cash | 229.78K | — |
| Total | 298.85K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
298.85K
Market value
$1.95M
8/21/2026
Total
Units
298.85K
Value
$1.95M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/21/2026 | 298.85K | $1.95M | NASDAQ | Planned |
| Total | 298.85K | $1.95M | ||